Validation of atovaquone plasma levels by liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring in pediatric patients-Reference-Cited by-同舟云学术

Validation of atovaquone plasma levels by liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring in pediatric patients

Published:2022-11 Issue: Volume:26 Page:23-27
ISSN:2667-145X
Container-title:Journal of Mass Spectrometry and Advances in the Clinical Lab
language:en
Short-container-title:Journal of Mass Spectrometry and Advances in the Clinical Lab

Author:

Horvath Thomas D.^ORCID,Poventud-Fuentes Izmarie,Olayinka Lily,James Asha,Haidacher Sigmund J.,Hoch Kathleen M.^ORCID,Stevens Alexandra M.^ORCID,Haag Anthony M.^ORCID,Devaraj Sridevi

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Medical Laboratory Technology,Spectroscopy,Microbiology

Reference16 articles.

1. Antiparasitic Agent Atovaquone

2. FDA, Malarone label, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021078s023lbl.pdf, (accessed March 8, 2022).

3. FDA, Mepron label, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020500s019lbl.pdf, (accessed March 8, 2022).

4. Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii

5. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid Chromatography-Tandem Mass Spectrometry-Based Therapeutic Monitoring of Plasma Atovaquone Concentrations in Pediatric Patients;Methods in Molecular Biology;2023-12-01

2. Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated;Cancers;2023-02-20